Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
16.66
+0.58 (3.63%)
Nov 21, 2024, 11:19 AM EST - Market open
CRBP Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 19.42 | 13.72 | 17 | 25.01 | 85.43 | 31.75 | Upgrade
|
Short-Term Investments | 139.94 | 7.18 | 42.19 | 72.64 | - | - | Upgrade
|
Cash & Short-Term Investments | 159.36 | 20.91 | 59.2 | 97.65 | 85.43 | 31.75 | Upgrade
|
Cash Growth | 454.63% | -64.68% | -39.38% | 14.30% | 169.09% | -23.95% | Upgrade
|
Accounts Receivable | - | - | - | - | 1.62 | 2.68 | Upgrade
|
Other Receivables | - | - | - | - | 0.96 | - | Upgrade
|
Receivables | - | - | - | - | 2.58 | 2.68 | Upgrade
|
Prepaid Expenses | 1.24 | 2.45 | 0.79 | 2.37 | 3.71 | 3.72 | Upgrade
|
Restricted Cash | 0.29 | 0.19 | 0.19 | 0.19 | 0.35 | - | Upgrade
|
Total Current Assets | 160.89 | 23.55 | 60.18 | 100.2 | 92.07 | 38.15 | Upgrade
|
Property, Plant & Equipment | 2.9 | 4.04 | 5.5 | 7 | 9.32 | 10.9 | Upgrade
|
Other Long-Term Assets | 0.39 | 0.69 | 0.63 | 0.52 | 0.9 | 0.08 | Upgrade
|
Total Assets | 164.17 | 28.27 | 66.31 | 107.73 | 102.29 | 49.14 | Upgrade
|
Accounts Payable | 2.89 | 3.18 | 2.17 | 1.78 | 7.38 | 11.09 | Upgrade
|
Accrued Expenses | 7.18 | 11.03 | 6 | 10.09 | 22.01 | 22.45 | Upgrade
|
Current Portion of Long-Term Debt | - | 16.21 | 3.15 | 3.86 | 0.71 | 0.75 | Upgrade
|
Current Portion of Leases | 1.56 | 1.44 | 1.28 | 1.14 | 1 | 0.6 | Upgrade
|
Other Current Liabilities | - | 0.04 | 0.04 | 0.13 | 0.8 | - | Upgrade
|
Total Current Liabilities | 11.63 | 31.89 | 12.64 | 17.01 | 31.9 | 34.89 | Upgrade
|
Long-Term Debt | - | - | 15.98 | 15.64 | 18.03 | - | Upgrade
|
Long-Term Leases | 2.05 | 3.24 | 4.68 | 5.96 | 7.09 | 8.1 | Upgrade
|
Other Long-Term Liabilities | - | 0.04 | 0.02 | 0.02 | - | - | Upgrade
|
Total Liabilities | 13.67 | 35.18 | 33.32 | 38.62 | 57.02 | 42.98 | Upgrade
|
Common Stock | 0 | 0 | 0 | 0 | 0.01 | 0.01 | Upgrade
|
Additional Paid-In Capital | 617.65 | 429.78 | 425.2 | 418.9 | 349.36 | 198.98 | Upgrade
|
Retained Earnings | -467.36 | -436.68 | -392.08 | -349.73 | -304.09 | -192.82 | Upgrade
|
Comprehensive Income & Other | 0.21 | -0 | -0.13 | -0.06 | - | - | Upgrade
|
Total Common Equity | 150.5 | -6.9 | 32.99 | 69.11 | 45.27 | 6.16 | Upgrade
|
Shareholders' Equity | 150.5 | -6.9 | 32.99 | 69.11 | 45.27 | 6.16 | Upgrade
|
Total Liabilities & Equity | 164.17 | 28.27 | 66.31 | 107.73 | 102.29 | 49.14 | Upgrade
|
Total Debt | 3.61 | 20.88 | 25.09 | 26.59 | 26.84 | 9.45 | Upgrade
|
Net Cash (Debt) | 155.75 | 0.02 | 34.11 | 71.06 | 58.6 | 22.3 | Upgrade
|
Net Cash Growth | 2550.45% | -99.94% | -52.00% | 21.26% | 162.73% | -46.07% | Upgrade
|
Net Cash Per Share | 17.36 | 0.01 | 8.18 | 17.35 | 22.50 | 10.47 | Upgrade
|
Filing Date Shares Outstanding | 12.18 | 10.49 | 4.17 | 4.17 | 4.17 | 2.42 | Upgrade
|
Total Common Shares Outstanding | 12.18 | 4.42 | 4.17 | 4.17 | 3.3 | 2.16 | Upgrade
|
Working Capital | 149.27 | -8.35 | 47.54 | 83.2 | 60.18 | 3.27 | Upgrade
|
Book Value Per Share | 12.36 | -1.56 | 7.91 | 16.56 | 13.74 | 2.86 | Upgrade
|
Tangible Book Value | 150.5 | -6.9 | 32.99 | 69.11 | 45.27 | 6.16 | Upgrade
|
Tangible Book Value Per Share | 12.36 | -1.56 | 7.91 | 16.56 | 13.74 | 2.86 | Upgrade
|
Machinery | 1.2 | 1.2 | 1.38 | 1.43 | 2.25 | 2.34 | Upgrade
|
Leasehold Improvements | 3.33 | 3.33 | 3.33 | 3.33 | 4.16 | 4.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.